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Abstract
The clinical distinction of different types of renal bone disease is not easy and plasma intact
parathyroid hormone remains the most widely used noninvasive test to predict bone histology. We
studied the bone biopsy histology of 15 chronic hemodialysis patients and evaluated the usefulness
of plasma intact parathyroid hormone in predicting the types of renal bone disease. The plasma
intact parathyroid hormone of high turnover hyperparathyroid bone disease in hemodialysis patients
was 316.3 ± 162.8 ng/L and that of non-high-turnover was 144.1 ± 108.9 ng/L (p=0.034). The
plasma intact parathyroid hormone of low turnover bone disease in hemodialysis patients was
127.0 ± 105.7 ng/L and that of non-low-turnover was 290.4 ± 161.1 ng/L (p=0.033). The thresholds
of plasma intact parathyroid hormone for distinguishing osteodystrophy and sensitivity, specificity
of plasma intact parathyroid hormone were analyzed by using receiver operating characteristic
curve analysis. The area under receiver operating characteristic of plasma intact parathyroid
hormone in diagnosing of hyperparathyroid bone disease and low turnover bone disease was 0.84
and 0.82, respectively. The optimal cutoff value of plasma intact parathyroid hormone for diagnosis
of hyperparathyroid bone disease was 250 ng/L (sensitivity, 75%; specificity, 71.4%), and that of
low turnover bone disease was 100 ng/L (sensitivity, 60%; specificity, 90%). We conclude that
plasma intact parathyroid hormone is useful in predicting hyperparathyroid bone histology, but
the sensitivity in predicting low turnover bone histology is low.
Key words: Bone histomorphometry, Plasma intact parathyroid hormone, Receiver operating characteristic,
Renal osteodystrophy
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PTH and bone turnover, debate still exists about the
ability of PTH to predict bone histology in an individual
patient. Table 2 illustrates the variations in the PTH
threshold for distinguishing low turnover and high
turnover states in reported literature. The clinical
interpretations of these studies were hampered for a
number of reasons. These include differences in selection
criteria and indications for bone biopsy, variations in
exposure to aluminium and vitamin D derivatives, and
differences between the PTH assays used. In this study,
we recruited only patients with minimal aluminium
exposure and with no effect of vitamin D derivatives in
the past month. We found that osteitis fibrosa or HTBD
hyperparathyroidism (osteitis fibrosa) was 250 ng/L
(sensitivity, 75%; specificity, 71.4%), and for LTBD was
below 100 ng/L (sensitivity, 60%; specificity, 90%).
Maximum likelihood ratio for HTBD and LTBD were
2.9 and 6, respectively.
DISCUSSION
In this study, we used ROC analysis for identifying
thresholds of iPTH level for high and low bone turnover
disease. Receiver operating characteristic curves are used
to determine the appropriate cutoff values in the diagnosis
of various conditions (5).
Although a reasonably close correlation exists between
Type of bone disease Criteria
Osteitis fibrosa Fibrosis area/bone area ≥0.5%
Osteomalacia Osteoid area/bone area ≥15% and BFR <195 μm2/mm2●d-1
Adynamic bone disease Osteoid area/bone area <15% and BFR <195 μm2/mm2●d-1
High bone turnover BFR >411 μm2/mm2●d-1
Low bone turnover BFR <195 μm2mm2●d-1
BFR = bone formation rate
Table 1. The histomorphometric indices.
Figure 1. Correlation between iPTH and fibrosis area/bone area.
Reasonably correlation were showed between iPTH and non-high
BFR (<411 μm2/mm2●d-1). See Figure 2 (r=0.55).
Figure 2. Correlation between iPTH and non-high BFR.
Figure 3. ROC curve of fibrosis area/bone area %, criterion was
iPTH.
Figure 4. ROC curve of BFR, criterion was iPTH.
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iPTH for renal osteodystrophy
Low BFR (n = 5) Non-low BFR (n = 10) Reference range (4)
OS/BS, % 54.85 ± 18.4 51.0 ± 18.9 12.8-27
Fibrosis area/bone area, % 0.16 ± 0.18* 2.5 ± 1.8 0
Osteoid area/bone area, % 7.5 ± 9.1 4.86 ± 3.22 1.7-5.1
Mineral apposition rate, μm/d 0.27 ± 0.053† 0.61 ± 0.2 0.55-0.84
BFR, μm2/mm2●d-1 105.6 ± 41.2‡ 390.7 ± 169.2 195-411
iPTH, ng/L 127.0 ± 105.7 290.4 ± 161.1§ 10-65
OS/BS = osteoid surface/fraction of trabecular bone lined by osteoid seams
*p=0.014.
†p=0.003.
‡p=0.003.
§p=0.033.
Table 2. Bone biopsy indices of the studied patient segregated to low turnover and non-low turnover bone disease.
Reference Type of patients (n) Aluminium Bone disease                       PTH
exposure Threshold Sensitivity Specificity PPV NPV
[6] ESRD (30) Low ABD <1 88   91   78 95
HPT >3 83   88   88 84
[7] HD (49) Low ABD <2 59   94   90 70
CAPD (32) HPT >7 50 100 100 67
[8] HD (66) Low ABD <2 - -   75 75
HPT >3.5 88 -   82 91
CAPD (109) HPT >5.5 68 -   87 95
[9] HD (45) High HPT >7 60 100 100 61
CAPD (34) HPT >7 65   96   92 78
[10] HD (114) High ABD <1 69   89   45 96
HPT >3 87   60   78 74
HD (40)a Low HPT >3 88   88   97 58
ABD = adynamic bone disease; CAPD = continuous ambulatory peritoneal dialysis; ESRD = end-stage renal disease; HD = hemodialysis;
HPT = hyperparathyroid bone disease; NPV = negative predictive value; PPV = positive predictive value; NR = data not reported
Parathyroid hormone threshold is expressed as multiple of upper limit of normal range. aSubgroup without bone aluminium deposition on
bone biopsy.
Table 3. Ability of intact parathyroid hormone to predict bone histology.
cannot be predicted by BFR. So we use fibrosis area/
bone area as criterion to determine the cutoff value of
iPTH in predicting HTBD through analysis of ROC. The
cutoff value of iPTH in this study (250 ng/L) was similar
to the results as reported previously. For low bone
turnover states, we use BFR as indices to determine the
low turnover states cutoff value of iPTH by using ROC
analysis. Our results showed that the value of iPTH for
low turnover (100 ng/L) was similar to the reports by Qi
Q and Gerakis A (9,10). Although the area under ROC
curve was acceptable 0.82, the sensitivity of iPTH in
predicting low turnover states was low, which was almost
the same as the sensitivity reported by Wang M and Qi
Q (7,8). This indicated that low turnover states are more
difficult to diagnose with noninvasive techniques. In such
instance, a bone biopsy will be useful.
Determining the cutoff value of PTH is very important
because it appears that atherosclerotic calcification is an
actively regulated process similar to bone formation.
Cells capable of osteoblastic differentiation and
calcification have bee found in coronary arteries with
atherosclerotic plaques but not in normal uninjured
coronary ar tery  segments  (11) .  The precise
pathophysiology of coronary calcification is unclear at
this time however elevation of PTH was an independent
risk factor of metastatic calcification.
We conclude that the ability of PTH to predict bone
histology is better in populations who have not been
exposed to aluminium. In such settings the threshold
value for the diagnosis of LTBD varies from the upper
limit to twice the upper limit of normal, whereas PTH
values in excess of three to four times the upper limit of
normal are associated with HTBD. Nevertheless there
remains a "grey zone" of PTH values that can be
associated with low, normal or high bone turnover.
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